Cutler Group LP Zymeworks Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	BUY	$4.65 - $7.43 $2,790 - $4,458	600 New	600 $0
Q1 2021 Apr 26, 2021	BUY	$29.83 - $56.81 $17,898 - $34,086	600 Added 200.0%	900 $1,000
Q3 2020 Oct 27, 2020	SELL	$29.21 - $46.58 $8,763 - $13,974	-300 Reduced 50.0%	300 $0
Q2 2020 Jul 22, 2020	SELL	$33.67 - $40.0 $121,212 - $144,000	-3,600 Reduced 85.71%	600 $1,000
Q1 2020 May 07, 2020	BUY	$24.28 - $49.8 $72,840 - $149,400	3,000 Added 250.0%	4,200 $46,000
Q4 2019 Feb 06, 2020	BUY	$24.84 - $45.46 $29,808 - $54,552	1,200 New	1,200 $1,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $903M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.